Benzodiazepine derivatives

Libervant

Approved 30 Aug 2022BuccalFilm

The FDA lists this product in 12 strengths and forms.

Official labelAsk Osler about it

Composition

Active ingredients: DIAZEPAM 7.5MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application NDA212641.

Open Drugs@FDA

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Libervant
Active substance: diazepam
Drug class: Benzodiazepine derivatives
Group: Benzodiazepines
Route: Buccal
Dosage form: Film
Applicant: Aquestive
Status: Tentative approval
FDA approval: 30 Aug 2022
Application: NDA212641-002
RxCUI: 2682565

Guidelines

FDA 2023

Zolpidem TartrateCapsule

MidazolamSpray

Midazolam Hydrochloride (Autoinjector)midazolam hydrochloride · Solution

Midazolam in 0.8% Sodium Chloridemidazolam · Solution

Loreev XRlorazepam · Capsule, extended release

Midazolam in 0.9% Sodium Chloridemidazolam · Solution

Chlordiazepoxide Hydrochloride and Clidinium Bromidechlordiazepoxide hydrochloride · Capsule

Valtocodiazepam · Spray

Nayzilammidazolam · Spray

Sympazanclobazam · Film

ClobazamTablet

Seizalammidazolam hydrochloride · Solution

EszopicloneTablet

LorazepamConcentrate

Edluarzolpidem tartrate · Tablet

AlprazolamTablet, orally disintegrating

ZaleplonCapsule